{"data":[{"banner_image":"649e5129-dd4a-49a3-aa47-2ba135ff5b12","banner_image_attribution_text":"Banner photo by Cassi Josh","banner_image_attribution_url":"https://unsplash.com/@flyd2069","banner_text":"Endovanta’s Innovations in Cardiovascular Medicine","banner_logo":"5dd4a91b-8b91-4e8e-b76f-6f90b15c55a3","info_html":"

THIS PAGE IS DUMMY INFORMATION CREATED FOR DEMO PURPOSES. Some of the content on this page has been created using generative AI. Endovanta Therapeutics is a fictional biotech / pharma company. Zentavril is a fictional drug for heart failure.

How to navigate this demo of Kudos for Pharma:
Follow the orange tile (top left, below) to \"Zentavril CME: Advancing Clinical Practice in Heart Failure\".

What information would normally be shown on this page?
You would use this area to introduce your company, drug, trial or therapy area. You can include calls to action and relevant links e.g. Visit our medical information content hub.

Seen enough? Contact eliza.brodie@growkudos.com to set up a proper online demo where she can take you through the full product including the service options, metrics, and pricing.

","banner_title":"Endovanta’s Innovations in Cardiovascular Medicine","showcase_key":"collection/endovanta-pharma-demo","theme_color":"#D02F06","text_color":"light","promo_section_title":"Explore Our Pipeline in Heart Failure Treatment","promo_section_text":"

Discover how Endovanta is advancing care across the spectrum of heart failure. From novel mechanisms to patient-centered outcomes, each of our investigational and approved therapies addresses a distinct clinical need. Click through to explore the science, trial evidence, and medical education materials behind Zentavril, Cardemra, Volrizon, and Nureximab.

You can also use this section to include calls to action and relevant links, for example, a link to the European Society of Cardiology Congress where the poster is being presented, or the company's medical information content hub.

","featured_people_section_title":null,"featured_people_section_text":null,"featured_people_section_use_theme_color":false,"listing_title":"Kudos Pharma Demo - Endovanta","listed":true,"keywords":"pharma demo","promo_section_items":[{"showcase_promo_section_items_id":{"title":"Zentavril in Heart Failure: Evidence & Education","image":"891befc0-737e-4b3e-8b94-c85d1ed23716","description":"Zentavril: a novel therapy developed by Endovanta for patients with heart failure with reduced ejection fraction (HFrEF).","url":"/showcase/collections/zentavril-pharma-demo"}},{"showcase_promo_section_items_id":{"title":"Cardemra in HFpEF: Innovation in a Challenging Population","image":"2949fd0f-c1d4-4f60-9b57-6699f8c495f0","description":"Cardemra: an investigational sGC stimulator being developed by Endovanta to address the unmet needs of patients with heart failure with preserved ejection fraction (HFpEF).","url":"/showcase/collections/zentavril-pharma-demo"}},{"showcase_promo_section_items_id":{"title":"Volrizon: Targeting Electrophysiology in Heart Failure Management","image":"b368a5b9-aeab-45e0-a7ae-d34528cd0f68","description":"Volrizon: a novel oral potassium channel modulator designed to help stabilize cardiac rhythm and reduce arrhythmic burden in patients with chronic heart failure.","url":"/showcase/collections/zentavril-pharma-demo"}},{"showcase_promo_section_items_id":{"title":"Nureximab: Exploring Immune Modulation in Post-MI Heart Failure","image":"72c132f5-ebb6-456b-895f-32eec9139d37","description":"Nureximab: a monoclonal antibody under investigation by Endovanta for its potential to prevent adverse cardiac remodeling after myocardial infarction.","url":"/showcase/collections/zentavril-pharma-demo"}}],"featured_people_section_items":[],"compliance_disclaimer":{"title":"Please confirm you are a US Healthcare Professional","request_text":"

The information on this demo page is provided by Endovanta Therapeutics and is intended for healthcare professionals only. It is provided solely for the purpose of scientific exchange. By accessing this page you accept this legal disclaimer and you expressly confirm your status as a healthcare professional. The page is not intended to provide medical advice and/or treatment guidance.

This information is intended for healthcare professionals from the US. If you are accessing from outside the US, please visit our Global Showcase.

","question":"Are you a healthcare professional from the US?","refusal_text":"

You have indicated that you are not a healthcare professional from the US.

If this is incorrect, you can go back, or visit our home page.

","id":11,"in_page_statement":null}}]}

What is it about?

Who is involved?

Share